Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

Abstract Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with sc...

Full description

Bibliographic Details
Main Authors: Shintaro Sakai, Yoshiro Morimoto, Yusuke Matsuzaka, Takeshi Nakano, Shinji Kanegae, Akira Imamura, Hiroki Ozawa
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Neuropsychopharmacology Reports
Subjects:
blonanserin tablets
blonanserin transdermal patches
orofacial dyskinesia
Online Access:https://doi.org/10.1002/npr2.12200

Similar Items

Similar Items